Key Insights

Highlights

Treatment Research

3 treatments under study, led by Thrive4u Spectrum Lipases

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 1 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07893288Phase 1Not Yet Recruiting

A Study of Single and Combination Lipase Dietary Supplements to Increase Fatty Acid Absorption in Generally Health Adults

Showing all 1 trials

Research Network

Common Treatments

  • Thrive4u Spectrum Lipases1
  • Placebo1
  • Thrive4u Tg Lipase1

Active Sponsors

  • Nutrasource Pharmaceutical And Nutraceutical Services Inc1
  • Danisco1

Related Conditions

  • Healthy1
  • Gastrointestinal Symptoms1
  • Digestive Symptoms1

Activity Timeline